Merck & Company, Inc. · NYSE:MRK
The Vanguard Group reported a 10.02% stake in Merck & Company, Inc. (Schedule 13G/A)
Event Feb 28, 2025 · Filed Mar 6, 2025
The Vanguard Group reported a 10.02% stake in Merck & Company, Inc., 253,257,639 shares, as a passive investor on Feb 28, 2025. Filed Mar 6, 2025 (Schedule 13G/A).
- Stake
- 10.02%
- Shares
- 253,257,639
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.02% | 253,257,639 |
Source
Related
- Merck & Company, Inc.
- The Vanguard Group
- Merck & Company, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Guindo Chirfi · Aug 13, 2026
- Form 4 · Zachary Jennifer · Aug 13, 2026
- Form 4 · DeLuca Richard R. · Aug 12, 2026
- Form 4 · DeLuca Richard R. · Aug 10, 2026
- Form 4 · Guindo Chirfi · Aug 7, 2026